by dschulz July 21, 2023 in Lectenz® Bio News 0 0 The National Institute of Health (NIH) Office of Research Infrastructure Programs (ORIP) awards Lectenz Bio an SBIR Fast-Track to develop N-glycan binding reagents and tools. Related Posts Lectenz Bio receives NIH SBIR Fast-TrackThe National Institute of Health (NIH) Office of Research Infrastructure Programs (ORIP) awards Lectenz Bio… Lectenz Bio receives NIH SBIR Phase IIThe National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop… Lectenz Bio receives NIH SBIR Phase IThe National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio a second SBIR Phase I to apply… Related Posts CEO Lori Yang Co-Authored Nature Communications Paper, Featuring SiaFind™ GlycoSense Paper Published in Scientific Reports
